Financials Illumina, Inc.

Equities

ILMN

US4523271090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-17 EDT			5-day change	1st Jan Change
130.21 ^USD	+0.53%		+4.90%	-6.49%

09-13	RBC Raises Price Target on Illumina to $252 From $242, Keeps Outperform Rating	MT
09-06	European Commission Withdraws Previous Decisions on Illumina-Grail Merger After Court Ruling	MT

Projected Income Statement: Illumina, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	3,543	3,239	4,526	4,584	4,504	4,357	4,564	4,884
Change	-	-8.58%	39.73%	1.28%	-1.75%	-3.27%	4.76%	7.02%
EBITDA ¹	1,231	916	1,277	708	488	1,111	1,252	1,463
Change	-	-25.59%	39.41%	-44.56%	-31.07%	127.66%	12.66%	16.86%
EBIT ¹	1,076	758	1,096	487	247	901.1	1,016	1,156
Change	-	-29.55%	44.59%	-55.57%	-49.28%	264.8%	12.72%	13.79%
Interest Paid ¹	133	-	1,007	-157	-48	-13	-77	-
Earnings before Tax (EBT) ¹	1,118	856	884	-4,336	-1,117	-1,903	632.9	792.8
Change	-	-23.43%	3.27%	-	-74.24%	-70.38%	-	25.27%
Net income ¹	1,002	656	762	-4,404	-1,161	-1,158	479.6	658.4
Change	-	-34.53%	16.16%	-	-73.64%	0.25%	-	37.3%
Announcement Date	1/29/20	2/11/21	2/10/22	2/7/23	2/8/24	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2
Net sales ¹	907	953	859	633	794	953	1,093	1,126	1,108	1,198	1,223	1,162	1,115	1,083	1,087	1,176	1,119	1,122	1,076	1,112	1,081	1,110	1,099	1,132	1,148	1,190	1,161	1,197
Change	-	5.07%	-9.86%	-26.31%	25.43%	20.03%	14.69%	3.02%	-1.6%	8.12%	2.09%	-4.99%	-4.04%	-2.87%	0.37%	8.19%	-4.85%	0.27%	-4.1%	3.35%	-2.81%	2.67%	-0.98%	2.99%	1.41%	3.68%	-2.45%	3.17%
EBITDA ¹	365	336	326	139	209	242	393	379	307	196	263	194	159	90	80	143	154	113	93	143	262.6	274.1	282.2	296.3	291.7	307.4	308.3	308.2
Change	-	-7.95%	-2.98%	-57.36%	50.36%	15.79%	62.4%	-3.56%	-19%	-36.16%	34.18%	-26.24%	-18.04%	-43.4%	-11.11%	78.75%	7.69%	-26.62%	-17.7%	53.76%	83.66%	4.38%	2.93%	5%	-1.53%	5.39%	0.28%	-0.04%
EBIT ¹	327	296	289	100	170	199	351	338	260	146	212	141	102	31	21	82	93	51	33	84	216.4	237.2	236.9	244.2	255.5	269.2	268.3	265.1
Change	-	-9.48%	-2.36%	-65.4%	70%	17.06%	76.38%	-3.7%	-23.08%	-43.85%	45.21%	-33.49%	-27.66%	-69.61%	-32.26%	290.48%	13.41%	-45.16%	-35.29%	154.55%	157.67%	9.6%	-0.15%	3.11%	4.63%	5.36%	-0.36%	-1.19%
Charge d'intérêts ¹	-	1	-	0.069	53	166	-24	20	-	45	-6	-	-6	-41	-20	1	-28	-4	-6	-11	-11	-11	-29	-29	-	-	-	-
Earnings before Tax (EBT) ¹	270	269	178	165	215	298	169	207	420	86	140	-637	-3,672	-168	-78	-89	-782	-168	-109	-1,976	127	142	141.8	137.7	183.2	200.2	209	198
Change	-	-0.37%	-33.83%	-7.3%	30.3%	38.6%	-43.29%	22.49%	102.9%	-79.52%	62.79%	-	476.45%	-95.42%	-53.57%	14.1%	778.65%	-78.52%	-35.12%	1,712.84%	-	11.77%	-0.18%	-2.83%	32.97%	9.34%	4.37%	-5.26%
Net income ¹	234	239	173	47	179	257	147	185	317	112	86	-535	-3,816	-140	3	-234	-754	-176	-126	-1,988	77.03	88.7	100.2	95.2	127.6	139.4	157	148
Change	-	2.14%	-27.62%	-72.83%	280.85%	43.58%	-42.8%	25.85%	71.35%	-64.67%	-23.21%	-	613.27%	-96.33%	-	-	222.22%	-76.66%	-28.41%	1,477.78%	-	15.14%	12.97%	-4.99%	34.03%	9.29%	12.59%	-5.73%
Announcement Date	10/24/19	1/29/20	4/30/20	8/6/20	10/29/20	2/11/21	4/27/21	8/5/21	11/4/21	2/10/22	5/5/22	8/11/22	11/3/22	2/7/23	4/25/23	8/9/23	11/9/23	2/8/24	5/2/24	8/6/24	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Illumina, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-2,273	-2,288	356	698	435	860	-45.9	-792
Change	-	-200.66%	-84.44%	96.07%	-37.68%	97.7%	-105.34%	-1,825.49%
Announcement Date	1/29/20	2/11/21	2/10/22	2/7/23	2/8/24	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Illumina, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	209	189	208	286	195	185.1	194.9	203.7
Change	-	-9.57%	10.05%	37.5%	-31.82%	-5.07%	5.27%	4.51%
Free Cash Flow (FCF) ¹	842	891	337	106	283	1,978	2,066	1,301
Change	-	5.82%	-62.18%	-68.55%	166.98%	598.98%	4.44%	-37.02%
Announcement Date	1/29/20	2/11/21	2/10/22	2/7/23	2/8/24	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Illumina, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	34.74%	28.28%	28.21%	15.45%	10.83%	25.5%	27.42%	29.95%
EBIT Margin (%)	30.37%	23.4%	24.22%	10.62%	5.48%	20.68%	22.25%	23.66%
EBT Margin (%)	31.56%	26.43%	19.53%	-94.59%	-24.8%	-43.68%	13.87%	16.23%
Net margin (%)	28.28%	20.25%	16.84%	-96.07%	-25.78%	-26.58%	10.51%	13.48%
FCF margin (%)	23.77%	27.51%	7.45%	2.31%	6.28%	45.4%	45.27%	26.64%
FCF / Net Income (%)	84.03%	135.82%	44.23%	-2.41%	-24.38%	-170.8%	430.8%	197.61%
Profitability
ROA	13.67%	8.91%	7.82%	2.45%	1.23%	-9.8%	11.35%	16.1%
ROE	23.08%	14.27%	11.56%	3.88%	2.22%	12.79%	17.89%	16.75%
Financial Health
Leverage (Debt/EBITDA)	-	-	0.28x	0.99x	0.89x	0.77x	-	-
Debt / Free cash flow	-	-	1.06x	6.58x	1.54x	0.43x	-	-
Capital Intensity
CAPEX / Current Assets (%)	5.9%	5.84%	4.6%	6.24%	4.33%	4.25%	4.27%	4.17%
CAPEX / EBITDA (%)	16.98%	20.63%	16.29%	40.4%	39.96%	16.66%	15.57%	13.92%
CAPEX / FCF (%)	24.82%	21.21%	61.72%	269.81%	68.9%	9.36%	9.43%	15.65%
Items per share
Cash flow per share ¹	7.054	7.297	3.609	2.497	3.025	4.485	7.01	8.3
Change	-	3.45%	-50.54%	-30.82%	21.17%	48.26%	56.28%	18.41%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	31.38	31.93	68.41	-	36.13	22.36	30.9	28.86
Change	-	1.76%	114.23%	-	-	-38.13%	38.21%	-6.6%
EPS ¹	6.74	4.45	5.04	-28	-7.34	-9.877	3.524	4.392
Change	-	-33.98%	13.26%	-655.56%	-73.79%	34.57%	-135.68%	24.64%
Nbr of stocks (in thousands)	147,000	146,000	156,305	157,300	158,800	159,300	159,300	159,300
Announcement Date	1/29/20	2/11/21	2/10/22	2/7/23	2/8/24	-	-	-